BCCIP and neoplasm: BCCIP downregulation alone in the mouse mammary gland is sufficient to trigger the formation of benign mammary nodules but these benign lesions can hardly progress into malignant stages, supporting BCCIP as a suppressor for tumor initiation but a requisite for tumor progression.